Delivery Order SPE2DE21D7009-SPE2D626F71V6
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $31,771.22 fixed-price delivery order (Contract No. 4570331497) on December 15, 2025, for pain management medical devices and related services. The award carries an economic price adjustment clause and is scheduled for completion by December 29, 2025. This delivery order was issued under the company's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,838.13 for pain management medical devices under a fixed-price contract with economic price adjustment provisions. The award, issued on November 28, 2025, with an ultimate completion date of December 17, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division, a defense-related procurement entity supporting the Department of Defense. The...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a fixed-price delivery order valued at $43,709.82 on December 15, 2025, for pain management medical devices and equipment. The delivery order, with a ultimate completion date of December 22, 2025, will be performed in Valencia, California, and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-related procurement entity within the Department of Defense. This award carries no small...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $1,867.00 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment authority has an ultimate completion date of February 6, 2026, and will be performed in Valencia, California. The award was made without a set-aside designation by the Medical Supply Chain, a defense-related procurement entity within...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $36,589.22 on September 9, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of September 19, 2025, and is being performed in Valencia, California. The award carries no set-aside designation, indicating open competition in the federal marketplace. The contract is funded through the Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a delivery order valued at $2,683.75 for pain management medical devices on November 28, 2025, with an ultimate completion date of December 5, 2025. The contract employs fixed-price pricing with economic price adjustment and is issued without a small business set-aside. The work will be performed in Valencia, California, under the Defense Logistics Agency's Medical Supply Chain procurement entity....
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $1,834.00 on November 28, 2025, for pain management medical devices and services. The delivery order, which is fixed price with economic price adjustment provisions, has an ultimate completion date of December 5, 2025, and will be performed in Valencia, California. This award represents a child delivery order issued under Boston Scientific Neuromodulation's larger indefinite...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, received a delivery order award valued at $38,124.85 on December 19, 2025, for pain management medical devices and services. This fixed-price delivery order with economic price adjustment will be completed by December 29, 2025, and represents a child contract issued under a larger indefinite delivery vehicle—the SPE2DE contract held by Boston Scientific Neuromodulation with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $43,709.82 fixed-price delivery order with economic price adjustment on December 15, 2025, for pain management medical devices and related services. The delivery order, which is part of the larger SPE2DE indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical branch valued at $83.1 million through August 2026, carries no small business set-aside designation. Work...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $26,980 delivery order on November 28, 2025, for pain management medical devices and services. The contract, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by December 5, 2025, and will be performed in Valencia, California. This delivery order was issued without a set-aside designation and is funded through the Defense Department's...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F71V6Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a $36,969.82 delivery order (Contract Number 4570386394) to Boston Scientific Neuromodulation Corp for pain management medical devices on December 31, 2025, with an ultimate completion date of January 9, 2026. This fixed-price contract with economic price adjustment authority represents a child delivery order issued under the company's larger SPE2DE indefinite delivery contract valued at $83.1 million through August 16, 2026. The award carries no small business set-aside designation and will be performed at the contractor's facility in Valencia, California. Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation headquartered in Marlborough, Massachusetts, specializes in advanced neuromodulation therapies and non-opioid pain management solutions, including spinal cord stimulation systems, implantable pain pumps, and radiofrequency ablation devices designed for military treatment facilities and Veterans Affairs medical centers. The delivery order supports the Department of Defense's pain management capabilities for service members and veterans, leveraging Boston Scientific Neuromodulation's established portfolio of proprietary solutions such as RestoreSensor and Spectra WaveWriter spinal cord stimulators, along with associated accessories, training, and technical support services. The parent entity, Boston Scientific Corp, maintains an extensive federal presence across multiple therapeutic areas and serves as a critical supplier to the Defense Health Agency and Department of Veterans Affairs through numerous prime contracts and indefinite delivery vehicles. This particular delivery order represents routine fulfillment under an established contract vehicle that enables rapid procurement of specialized pain management technologies across the defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.0k | 12/30/25 |